James E. Flynn - Aug 11, 2025 SCHEDULE 13G Report for BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Management Company, L.P.
Security
BridgeBio Oncology Therapeutics, Inc. Common Stock
Symbol
BBOT
Shares outstanding
79.2M shares
Disclosed Ownership
4.89M shares
Ownership
6.17%
Form type
SCHEDULE 13G
Date filed
8/18/2025, 05:59 PM
Date of event
Aug 11, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 3.08% 2.44M 0 2.44M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Mgmt V, L.P. 3.08% 2.44M 0 2.44M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 3.08% 2.44M 0 2.44M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Private Design Fund V, L.P. 3.08% 2.44M 0 2.44M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 6.17% 4.89M 0 4.89M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 6.17% 4.89M 0 4.89M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact